Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
1.000
-0.090 (-8.26%)
Nov 4, 2024, 4:00 PM EST - Market closed

Biofrontera Revenue

Biofrontera had revenue of $7.84M in the quarter ending June 30, 2024, with 34.05% growth. This brings the company's revenue in the last twelve months to $35.24M, up 21.33% year-over-year. In the year 2023, Biofrontera had annual revenue of $34.07M with 18.82% growth.

Revenue (ttm)
$35.24M
Revenue Growth
+21.33%
P/S Ratio
0.09
Revenue / Employee
$414,600
Employees
85
Market Cap
5.54M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202334.07M5.40M18.82%
Dec 31, 202228.67M4.57M18.98%
Dec 31, 202124.10M5.25M27.86%
Dec 31, 202018.85M-7.33M-28.01%
Dec 31, 201926.18M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sunshine Biopharma 30.48M
Kindly MD 3.10M
Xenetic Biosciences 2.52M
Mainz Biomed 917.20K
Eterna Therapeutics 162.00K
Revenue Rankings